Mitsugumin 53 mitigation of ischemia–reperfusion injury in a mouse model-Reference-Cited by-同舟云学术

Mitsugumin 53 mitigation of ischemia–reperfusion injury in a mouse model

Published:2023-08 Issue: Volume: Page:
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Gouchoe Doug A.,Lee Yong Gyu,Kim Jung Lye,Zhang Zhentao,Marshall Joanna M.,Ganapathi Asvin,Zhu Hua,Black Sylvester M.,Ma Jianjie,Whitson Bryan A.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference35 articles.

1. OPTN/SRTR 2019 annual data report: heart;Colvin;Am J Transplant,2021

2. OPTN/SRTR 2019 annual data report: deceased organ donors;Israni;Am J Transplant,2021

3. Primary graft dysfunction in lung transplantation: a review of mechanisms and future applications;Chacon-Alberty;Transplantation,2023

4. Risk factors for primary graft dysfunction after lung transplantation;Whitson;J Thorac Cardiovasc Surg,2006

5. A single-center experience of 1500 lung transplant patients;Balsara;J Thorac Cardiovasc Surg,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex Vivo Lung Perfusion and Primary Graft Dysfunction Following Lung Transplantation: A Contemporary United Network for Organ Sharing Database Analysis;Journal of Clinical Medicine;2024-07-29

2. Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion;Journal of Visualized Experiments;2024-06-14

3. Improving lung allograft function in the early post-operative period through the inhibition of pyroptosis;Medical Review;2024-05-16

4. MG53/TRIM72: multi-organ repair protein and beyond;Frontiers in Physiology;2024-04-12

5. The Next Frontier in Lung Transplantation: Protecting the Endothelium and Repairing Organs for Transplant Utilizing MG53;Clinical and Translational Discovery;2023-11-15